PubMed

Weight loss with liraglutide, a once-daily human glucagon-like peptide-1 analogue for type 2 diabetes treatment as monotherapy or added to metformin, is primarily as a result of a reduction in fat tissue.

Jendle J, Nauck MA, Matthews DR, Frid A, Hermansen K, Düring M, Zdravkovic M, Strauss BJ, Garber AJ; LEAD-2 and LEAD-3 Study Groups.

Diabetes Obes Metab. 2009 Dec;11(12):1163-72.PMID: 19930006 [PubMed - in process]

Three cases of death caused by shots from blank cartridge.

Zdravkovic M, Milic M, Stojanovic M, Kostov M.

Am J Forensic Med Pathol. 2009 Dec;30(4):403-6.PMID: 19901805 [PubMed - in process]Related articles

Preoperative echocardiographic parameters influencing quality of life five years after coronary artery bypass graft surgery.

Zdravković M, Ristić M, Milić N, Zdravković D, Krotin M, Randjelović T.

Vojnosanit Pregl. 2009 Sep;66(9):718-23.PMID: 19877550 [PubMed - in process]Related articles

Absence of QTc prolongation in a thorough QT study with subcutaneous liraglutide, a once-daily human GLP-1 analog for treatment of type 2 diabetes.

Chatterjee DJ, Khutoryansky N, Zdravkovic M, Sprenger CR, Litwin JS.

J Clin Pharmacol. 2009 Nov;49(11):1353-62. Epub 2009 Sep 8.PMID: 19737980 [PubMed - in process]Related articles

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial.

Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, Zdravkovic M, Ravn GM, Simó R; Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group.

Diabetologia. 2009 Oct;52(10):2046-55. Epub 2009 Aug 14.PMID: 19688338 [PubMed - in process]Related articlesFree article

Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU).

Marre M, Shaw J, Brändle M, Bebakar WM, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S; LEAD-1 SU study group.

Diabet Med. 2009 Mar;26(3):268-78.PMID: 19317822 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).

Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L; LEAD-4 Study Investigators.

Diabetes Care. 2009 Jul;32(7):1224-30. Epub 2009 Mar 16.PMID: 19289857 [PubMed - indexed for MEDLINE]Related articlesFree article

[Implication of late diagnosis for survival of patients with colorectal carcinoma]

Zdravković D, Bilanović D, Randelović T, Zdravković M, Tosković B.

Vojnosanit Pregl. 2009 Feb;66(2):135-40. Serbian. PMID: 19281125 [PubMed - indexed for MEDLINE]Related articles

Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes.

Courrèges JP, Vilsbøll T, Zdravkovic M, Le-Thi T, Krarup T, Schmitz O, Verhoeven R, Bugáñová I, Madsbad S.

Diabet Med. 2008 Sep;25(9):1129-31. No abstract available. PMID: 19183322 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (liraglutide effect and action in diabetes)-2 study.

Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, Zdravkovic M, Düring M, Matthews DR; LEAD-2 Study Group.

Diabetes Care. 2009 Jan;32(1):84-90. Epub 2008 Oct 17.PMID: 18931095 [PubMed - in process]Related articlesFree article

Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial.

Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B; LEAD-3 (Mono) Study Group.

Lancet. 2009 Feb 7;373(9662):473-81. Epub 2008 Sep 24.PMID: 18819705 [PubMed - indexed for MEDLINE]Related articles

[Evaluation of myocardial function in the presence of left ventricular hypertrophy in athletes and hypertensive patients]

Deljanin-Ilić M, Ilić S, Dordević D, Zdravković M, Ilić V.

Med Pregl. 2008 Mar-Apr;61(3-4):178-82. Serbian. PMID: 18773696 [PubMed - indexed for MEDLINE]Related articles

Tolerability, pharmacokinetics and pharmacodynamics of the once-daily human GLP-1 analog liraglutide in Japanese healthy subjects: a randomized, double-blind, placebo-controlled dose-escalation study.

Irie S, Matsumura Y, Zdravkovic M, Jacobsen LV, Kageyama S.

Int J Clin Pharmacol Ther. 2008 Jun;46(6):273-9.PMID: 18541123 [PubMed - indexed for MEDLINE]Related articles

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes.

Seino Y, Rasmussen MF, Zdravkovic M, Kaku K.

Diabetes Res Clin Pract. 2008 Aug;81(2):161-8. Epub 2008 May 20.PMID: 18495285 [PubMed - indexed for MEDLINE]Related articles

Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide.

Horowitz M, Vilsbøll T, Zdravkovic M, Hammer M, Madsbad S.

Diabetes Obes Metab. 2008 Jul;10(7):593-6. Epub 2008 Apr 22. No abstract available. PMID: 18435773 [PubMed - indexed for MEDLINE]Related articles

[Safety of simultaneous colon and liver resection for colorectal liver metastases]

Stojanović M, Stanojević G, Radojković M, Zlatić A, Jeremić L, Branković B, Jovanović M, Kostov M, Zdravković M, Milić D.

Vojnosanit Pregl. 2008 Feb;65(2):153-7. Serbian. PMID: 18365673 [PubMed - indexed for MEDLINE]Related articles

[Pulsed Doppler tissue imaging in the early diagnosis of coronary artery disease]

Zdravković M, Deljanin-Ilić M, Trifunović-Zamaklar D, Milinić N, Zdravković D, Milić N.

Med Pregl. 2007 Sep-Oct;60(9-10):444-8. Review. Serbian. PMID: 18265589 [PubMed - indexed for MEDLINE]Related articles

Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus.

Vilsbøll T, Brock B, Perrild H, Levin K, Lervang HH, Kølendorf K, Krarup T, Schmitz O, Zdravkovic M, Le-Thi T, Madsbad S.

Diabet Med. 2008 Feb;25(2):152-6. Epub 2008 Jan 14.PMID: 18201212 [PubMed - indexed for MEDLINE]Related articles

[William Stewart Halsted--110 years of the use of surgical gloves]

Zdravković D, Bilanović D, Dikić S, Zdravković M, Milinić N.

Med Pregl. 2007 Jul-Aug;60(7-8):405-8. Serbian. PMID: 17990811 [PubMed - indexed for MEDLINE]Related articles

[Acute appendicitis in a femoral hernia]

Zdravković D, Masirević R, Bilanović D, Mastrević V, Zdravković M, Milinić N.

Med Pregl. 2007 Jan-Feb;60(1-2):85-7. Serbian. PMID: 17853718 [PubMed - indexed for MEDLINE]Related articles

The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes.

Zdravkovic M, Kruse M, Rost KL, Møss J, Kecskes A.

Exp Clin Endocrinol Diabetes. 2007 Jun;115(6):405-6.PMID: 17701889 [PubMed - indexed for MEDLINE]Related articles

Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.

Wutte A, Plank J, Bodenlenz M, Magnes C, Regittnig W, Sinner F, Rønn B, Zdravkovic M, Pieber TR.

Exp Clin Endocrinol Diabetes. 2007 Jul;115(7):461-7.PMID: 17647145 [PubMed - indexed for MEDLINE]Related articles

[The influence of respiratory pattern on heart rate variability analysis in heart failure]

Zamaklar-Trifunović D, Seferović PM, Petrović M, Zivković M, Vukomanović G, Milić N, Ristić AD, Zdravković M.

Srp Arh Celok Lek. 2007 Mar-Apr;135(3-4):135-42. Serbian. PMID: 17642449 [PubMed - indexed for MEDLINE]Related articles

Liraglutide, a long-acting human glucagon-like peptide-1 analog, given as monotherapy significantly improves glycemic control and lowers body weight without risk of hypoglycemia in patients with type 2 diabetes.

Vilsbøll T, Zdravkovic M, Le-Thi T, Krarup T, Schmitz O, Courrèges JP, Verhoeven R, Bugánová I, Madsbad S.

Diabetes Care. 2007 Jun;30(6):1608-10. Epub 2007 Mar 19. No abstract available. PMID: 17372153 [PubMed - indexed for MEDLINE]Related articlesFree article

[A historical perspective of tissue Doppler--when the starlight illuminates the myocardial function]

Zdravković M, Deljanin-Ilić M, Milinić N, Zdravković D.

Med Pregl. 2006 Jan-Feb;59(1-2):85-7. Serbian. PMID: 17068898 [PubMed - indexed for MEDLINE]Related articles

[Friedrich Trendelenburg (1844 - 1924)--life and work]

Zdravković D, Bilanović D, Randelović T, Zdravković M.

Med Pregl. 2006 Mar-Apr;59(3-4):183-5. Serbian. PMID: 17066594 [PubMed - indexed for MEDLINE]Related articles

[Rene Favaloro--a surgeon who has changed the history of coronary disease]

Zdravković M, Zdravković D, Milić N, Milinić N, Dukanović B, Zamaklar-Trifunović D.

Med Pregl. 2006 May-Jun;59(5-6):281-5. Serbian. PMID: 17039915 [PubMed - indexed for MEDLINE]Related articles

Five weeks of treatment with the GLP-1 analogue liraglutide improves glycaemic control and lowers body weight in subjects with type 2 diabetes.

Nauck MA, Hompesch M, Filipczak R, Le TD, Zdravkovic M, Gumprecht J; NN2211-1499 Study Group.

Exp Clin Endocrinol Diabetes. 2006 Sep;114(8):417-23.PMID: 17039422 [PubMed - indexed for MEDLINE]Related articles

An open-label, parallel group study investigating the effects of age and gender on the pharmacokinetics of the once-daily glucagon-like peptide-1 analogue liraglutide.

Damholt B, Golor G, Wierich W, Pedersen P, Ekblom M, Zdravkovic M.

J Clin Pharmacol. 2006 Jun;46(6):635-41.PMID: 16707410 [PubMed - indexed for MEDLINE]Related articles

The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener, in healthy male subjects.

Zdravkovic M, Kruse M, Rost KL, Møss J, Kecskes A, Dyrberg T.

J Clin Pharmacol. 2005 Jul;45(7):763-72.PMID: 15951466 [PubMed - indexed for MEDLINE]Related articles

A double-blind, randomized, dose-response study investigating the pharmacodynamic and pharmacokinetic properties of the long-acting insulin analog detemir.

Plank J, Bodenlenz M, Sinner F, Magnes C, Görzer E, Regittnig W, Endahl LA, Draeger E, Zdravkovic M, Pieber TR.

Diabetes Care. 2005 May;28(5):1107-12.PMID: 15855574 [PubMed - indexed for MEDLINE]Related articlesFree article

Screening for congenital malformations by ultrasonography in the general population of pregnant women: factors affecting the efficacy.

Tabor A, Zdravkovic M, Perslev A, Møller LK, Pedersen BL.

Acta Obstet Gynecol Scand. 2003 Dec;82(12):1092-8.PMID: 14616252 [PubMed - indexed for MEDLINE]Related articles

Selective alterations of the first NREM sleep cycle in humans by a dopamine D1 receptor antagonist (NNC-687).

Eder DN, Zdravkovic M, Wildschiødtz G.

J Psychiatr Res. 2003 Jul-Aug;37(4):305-12.PMID: 12765853 [PubMed - indexed for MEDLINE]Related articles

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency.

Svensson J, Monson JP, Vetter T, Hansen TK, Savine R, Kann P, Bex M, Reincke M, Hagen C, Beckers A, Ilondo MM, Zdravkovic M, Bengtsson BA, Korbonits M; NN703 Clinical Research Group.

Clin Endocrinol (Oxf). 2003 May;58(5):572-80.PMID: 12699438 [PubMed - indexed for MEDLINE]Related articles

A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.

Zdravkovic M, Olsen AK, Christiansen T, Schulz R, Taub ME, Thomsen MS, Rasmussen MH, Ilondo MM.

Eur J Clin Pharmacol. 2003 Feb;58(10):683-8. Epub 2003 Feb 6.PMID: 12610745 [PubMed - indexed for MEDLINE]Related articles

[Multivascular disease in clinical practice]

Despotović N, Zdravković M.

Srp Arh Celok Lek. 2002 Sep-Oct;130(9-10):316-9. Serbian. PMID: 12577672 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects.

Elbrønd B, Jakobsen G, Larsen S, Agersø H, Jensen LB, Rolan P, Sturis J, Hatorp V, Zdravkovic M.

Diabetes Care. 2002 Aug;25(8):1398-404.PMID: 12145241 [PubMed - indexed for MEDLINE]Related articlesFree article

Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study.

Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, Richard M, Erhardtsen E, Thomsen MS, Lincoff AM, Badimon JJ.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):1036-41.PMID: 12067917 [PubMed - indexed for MEDLINE]Related articlesFree article

A new model for analyzing immunomodulation of T cell responses induced by oral administration of islet cell antigens.

Bregenholt S, Wang M, Zdravkovic M, Dyrberg T, Petersen JS.

Ann N Y Acad Sci. 2002 Apr;958:179-81.PMID: 12021102 [PubMed - indexed for MEDLINE]Related articles

The pharmacokinetics, pharmacodynamics, safety and tolerability of NN2211, a new long-acting GLP-1 derivative, in healthy men.

Agersø H, Jensen LB, Elbrønd B, Rolan P, Zdravkovic M.

Diabetologia. 2002 Feb;45(2):195-202.PMID: 11935150 [PubMed - indexed for MEDLINE]Related articles

The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects.

Zdravkovic M, Christiansen T, Eliot L, Agersoe H, Thomsen MS, Falch JF, Søgaard B, Ynddal L, Ilondo MM.

Growth Horm IGF Res. 2001 Feb;11(1):41-8.PMID: 11437473 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetic and pharmacodynamic modeling of NN703, a growth hormone secretagogue, after a single po dose to human volunteers.

Agersø H, Ynddal L, Søgaard B, Zdravkovic M.

J Clin Pharmacol. 2001 Feb;41(2):163-9.PMID: 11210396 [PubMed - indexed for MEDLINE]Related articles

Bioequivalence and relative bioavailability of three estradiol and norethisterone acetate-containing hormone replacement therapy tablets.

Zdravkovic M, Müller M, Larsen S, Degenkolb J, Pabst G.

Int J Clin Pharmacol Ther. 2001 Jan;39(1):41-6.PMID: 11204938 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the conformity of human growth hormone concentrations measured with the DPC Immulite and the Nichols Advantage assays.

Zdravkovic M, Christiansen T, Grosch K, Ilondo MM.

Clin Chem Lab Med. 2000 Aug;38(8):799-800. No abstract available. PMID: 11071076 [PubMed - indexed for MEDLINE]Related articles

The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.

Zdravkovic M, Søgaard B, Ynddal L, Christiansen T, Agersø H, Thomsen MS, Falch JE, Ilondo MM.

Growth Horm IGF Res. 2000 Aug;10(4):193-8.PMID: 11032702 [PubMed - indexed for MEDLINE]Related articles

Susceptibility of MHC class I expressing extravillous trophoblast cell lines to killing by natural killer cells.

Zdravkovic M, Aboagye-Mathiesen G, Guimond MJ, Hager H, Ebbesen P, Lala PK.

Placenta. 1999 Jul-Aug;20(5-6):431-40.PMID: 10419808 [PubMed - indexed for MEDLINE]Related articles

[Ochronosis--an autopsy case report]

Kostov M, Stanković Z, Tatić V, Spasić P, Zdravković M.

Vojnosanit Pregl. 1999 Jan-Feb;56(1):89-92. Serbian. PMID: 10230339 [PubMed - indexed for MEDLINE]Related articles

Role of the Fas/Fas ligand pathway in apoptotic cell death induced by the human T cell lymphotropic virus type I Tax transactivator.

Chen X, Zachar V, Zdravkovic M, Guo M, Ebbesen P, Liu X.

J Gen Virol. 1997 Dec;78 ( Pt 12):3277-85.PMID: 9400978 [PubMed - indexed for MEDLINE]Related articlesFree article

Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.

Tóth FD, Aboagye-Mathiesen G, Nemes J, Liu X, Andirkó I, Hager H, Zdravkovic M, Szabó J, Kiss J, Aranyosi J, Ebbesen P.

Virology. 1997 Mar 17;229(2):400-14.PMID: 9126252 [PubMed - indexed for MEDLINE]Related articles

High interferon alpha levels in placenta, maternal, and cord blood suggest a protective effect against intrauterine herpes simplex virus infection.

Zdravkovic M, Knudsen HJ, Liu X, Hager H, Zachar V, Aboagye-Mathiesen G, Ebbesen P.

J Med Virol. 1997 Mar;51(3):210-3.PMID: 9139085 [PubMed - indexed for MEDLINE]Related articles